Printer Friendly

Corindus Vascular Robotics, Acist Medical Systems Team to Improve Percutaneous Coronary Intervention Workflow.

M2 PHARMA-August 11, 2016-Corindus Vascular Robotics, Acist Medical Systems Team to Improve Percutaneous Coronary Intervention Workflow

(C)2016 M2 COMMUNICATIONS

- US-based vascular robotics specialist Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS) and cardiology imaging modalities developer Acist Medical Systems, Inc. are providing Fairview Southdale Hospital, Edina, Minnesota three technologies that improve workflow, the companies said.

The CorPath System is the first FDA-cleared robotic-assisted system for percutaneous coronary intervention, offering robotic precision that may improve clinical outcomes and protection for physicians and staff from serious occupational hazards in the cath lab.

Next, the Acist RXi technology provides the reassurance of accurate and reliable FFR measurements and the advantages of Rapid Exchange technology.

Acist CVi simplifies contrast injection for procedures while enhancing safety, efficiency, control and image quality.

Corindus Vascular Robotics is a global firm in robotic-assisted vascular interventions. The company's CorPath System is the first FDA-cleared medical device to bring robotic precision to both percutaneous coronary intervention and peripheral vascular intervention.

During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance stents and guidewires with millimeter-by-millimeter precision.

The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries.

With the CorPath System, Corindus Vascular Robotics brings robotic precision to complex, radial, coronary and peripheral procedures to help optimise clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures.

Acist Medical Systems, A Bracco Group Co, is an interventional and diagnostic technology company with a portfolio of products, including the world's first Rapid Exchange FFR and High Definition IVUS systems.

It also offers advanced contrast imaging systems for cardiovascular angiography and radiology imaging.

Headquartered in Eden Prairie, Minnesota, Acist has worldwide presence with over 300 direct employees and facilities in Silicon Valley, The Netherlands, Shanghai and Tokyo.

Bracco has headquarters in Milan, Italy, and was founded in 1927.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2016 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

 
Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Geographic Code:1U4MN
Date:Aug 11, 2016
Words:325
Previous Article:Market for Radiofrequency Ablation Devices for Pain to Reach USD 1.087bn by 2023, Transparency Market Research Predicts.
Next Article:Cempra names David Zaccardelli Pharm.D to board.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters